Lipocine Inc. (LPCN)

Lipocine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.04	6.21	4.77	3.15	2.95	19.22
Short-Term Investments	11.89	15.43	17.26	29.38	41.67	0.45
Cash & Short-Term Investments	17.94	21.63	22.04	32.53	44.62	19.67
Cash Growth	-20.46%	-1.82%	-32.26%	-27.09%	126.86%	39.80%
Accounts Receivable	-	-	-	0.58	-	-
Other Receivables	0.12	0.12	0.05	0.08	0.25	0
Receivables	0.12	0.12	0.05	0.66	0.25	0
Prepaid Expenses	0.36	0.57	0.77	0.95	1.51	0.66
Restricted Cash	-	-	-	-	-	5
Total Current Assets	18.42	22.32	22.86	34.14	46.38	25.33
Property, Plant & Equipment	0.13	0.17	0.12	0.13	0.01	-
Long-Term Investments	-	-	-	-	2.02	-
Long-Term Accounts Receivable	-	-	-	3.25	4.05	-
Other Long-Term Assets	0.02	0.02	0.02	0.02	0.02	0.02
Total Assets	18.58	22.51	23	37.54	52.48	25.35
Accounts Payable	0.44	0.27	1.4	0.6	1.29	1.6
Accrued Expenses	0.43	0.48	1.22	1.08	1.02	1.65
Current Portion of Long-Term Debt	-	-	-	-	2.31	3.33
Current Portion of Leases	0.25	0.44	-	-	-	-
Current Unearned Revenue	0.32	0.32	-	-	-	-
Other Current Liabilities	-	-	0.02	-	1	-
Total Current Liabilities	1.45	1.51	2.63	1.68	5.62	6.58
Long-Term Debt	-	-	-	-	-	2.26
Other Long-Term Liabilities	-	-	-	0.23	1.3	1.17
Total Liabilities	1.45	1.51	2.63	1.91	6.91	10.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	221	220.79	220.17	219.11	218.29	187.41
Retained Earnings	-203.84	-199.77	-199.78	-183.43	-172.67	-172.03
Treasury Stock	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04
Comprehensive Income & Other	-0	0.01	0.01	-0.02	-0.02	-
Shareholders' Equity	17.13	21	20.37	35.63	45.57	15.34
Total Liabilities & Equity	18.58	22.51	23	37.54	52.48	25.35
Total Debt	0.25	0.44	-	-	2.31	5.59
Net Cash (Debt)	17.68	21.19	22.04	32.53	44.33	14.08
Net Cash Growth	-20.71%	-3.82%	-32.26%	-26.62%	214.90%	103.40%
Net Cash Per Share	3.31	3.91	4.18	6.19	8.60	4.30
Filing Date Shares Outstanding	5.42	5.35	5.32	5.21	5.19	5.19
Total Common Shares Outstanding	5.37	5.35	5.32	5.21	5.19	4.12
Working Capital	16.97	20.81	20.23	32.46	40.76	18.75
Book Value Per Share	3.19	3.93	3.83	6.84	8.77	3.72
Tangible Book Value	17.13	21	20.37	35.63	45.57	15.34
Tangible Book Value Per Share	3.19	3.93	3.83	6.84	8.77	3.72
Machinery	-	1.39	1.3	1.29	1.15	1.14

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q